Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

IBI3042 Study in Healthy Participants and Overweight or Obese Participants

Eli Lilly · Phase 1 · Recruiting · Enrollment 104

NCT07793019

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Investigational Drug: IBI3042 (Part A)n/rn/rn/rn/rn/r
Investigational Drug: IBI3042 (Part B)n/rn/rn/rn/rn/r
Matching Placebo (Part B)n/rn/rn/rn/rn/r
Orforglipron (Part B)n/rn/rn/rn/rn/r
Matching Placebo (Part A)n/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.